Advertisement
Screener

SPARK THERAPEUTICS, INC. Proceeds from Stock Options Exercised

SPARK THERAPEUTICS, INC. Proceeds from Stock Options Exercised

SPARK THERAPEUTICS, INC. reported Proceeds from Stock Options Exercised of $17.91 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromStockOptionsExercised · last filed 2019-11-07

  • SPARK THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2019-09-30 was $1.37M, a 0.65% decline year-over-year.
  • SPARK THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2019-06-30 was $4.93M, a 52.67% decline year-over-year.
  • SPARK THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2019-03-31 was $11.61M, a 771.40% increase year-over-year.
  • SPARK THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2018-12-31 was $2.00M, a 45.73% decline year-over-year.
  • SPARK THERAPEUTICS, INC. proceeds from stock options exercised for fiscal 2018 was $15.13M, a 27.02% decline from fiscal 2017.
  • SPARK THERAPEUTICS, INC. proceeds from stock options exercised for fiscal 2017 was $20.73M, a 699.88% increase from fiscal 2016.
  • SPARK THERAPEUTICS, INC. proceeds from stock options exercised for fiscal 2016 was $2.59M, a 132.25% increase from fiscal 2015.
  • SPARK THERAPEUTICS, INC. proceeds from stock options exercised for fiscal 2015 was $1.12M.
Period endProceeds from Stock Options Exercised 3 monthProceeds from Stock Options Exercised 3 month as first filedProceeds from Stock Options Exercised 6 monthProceeds from Stock Options Exercised 6 month as first filedProceeds from Stock Options Exercised 9 monthProceeds from Stock Options Exercised 9 month as first filedProceeds from Stock Options Exercised 10 monthProceeds from Stock Options Exercised 12 monthProceeds from Stock Options Exercised 12 month as first filed
2019-09-30$1.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$6.30M
derived: sum of 2 quarters · filed 2019-11-07
$17.91M
10-Q · filed 2019-11-07
$19.91M
derived: sum of 4 quarters · filed 2019-11-07
2019-06-30$4.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$16.54M
10-Q · filed 2019-08-08
$18.54M
derived: sum of 3 quarters · filed 2019-08-08
$19.92M
derived: sum of 4 quarters · filed 2019-11-07
2019-03-31$11.61M
10-Q · filed 2019-05-10
$13.61M
derived: sum of 2 quarters · filed 2019-05-10
$14.99M
derived: sum of 3 quarters · filed 2019-11-07
$25.41M
derived: sum of 4 quarters · filed 2019-11-07
2018-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$3.38M
derived: sum of 2 quarters · filed 2019-11-07
$13.80M
derived: sum of 3 quarters · filed 2019-11-07
$15.13M
10-K · filed 2019-02-28
2018-09-30$1.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$11.80M
derived: sum of 2 quarters · filed 2019-11-07
$13.13M
10-Q · filed 2019-11-07
$16.82M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$10.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$11.75M
10-Q · filed 2019-08-08
$15.44M
derived: sum of 3 quarters · filed 2019-08-08
$27.31M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$1.33M
10-Q · filed 2019-05-10
$5.02M
derived: sum of 2 quarters · filed 2019-05-10
$16.90M
derived: sum of 3 quarters · filed 2019-05-10
$18.63M
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31$3.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$15.56M
derived: sum of 2 quarters · filed 2019-02-28
$17.30M
derived: sum of 3 quarters · filed 2019-02-28
$20.73M
10-K · filed 2019-02-28
$20.73M
10-K · filed 2018-02-27
2017-09-30$11.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$13.61M
derived: sum of 2 quarters · filed 2018-11-06
$17.04M
10-Q · filed 2018-11-06
$17.04M
10-Q · filed 2017-11-07
$17.80M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$1.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
$5.17M
10-Q · filed 2018-08-08
$5.17M
10-Q · filed 2017-08-02
$5.93M
derived: sum of 3 quarters · filed 2019-02-28
$6.72M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$3.43M
10-Q · filed 2018-05-08
$3.43M
10-Q · filed 2017-05-10
$4.19M
derived: sum of 2 quarters · filed 2019-02-28
$4.98M
derived: sum of 3 quarters · filed 2019-02-28
$5.83M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$757.80K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$1.55M
derived: sum of 2 quarters · filed 2019-02-28
$2.40M
derived: sum of 3 quarters · filed 2019-02-28
$2.59M
10-K · filed 2019-02-28
$2.59M
10-K · filed 2017-02-28
2016-09-30$789.69K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$1.64M
derived: sum of 2 quarters · filed 2017-11-07
$1.83M
10-Q · filed 2017-11-07
$2.86M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$848.33K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$1.04M
10-Q · filed 2017-08-02
$2.07M
derived: sum of 3 quarters · filed 2018-02-27
$2.16M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$196.18K
10-Q · filed 2017-05-10
$1.22M
derived: sum of 2 quarters · filed 2018-02-27
$1.31M
derived: sum of 3 quarters · filed 2018-02-27
$1.31M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$1.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$1.12M
derived: sum of 2 quarters · filed 2018-02-27
$1.12M
derived: sum of 3 quarters · filed 2018-02-27
$1.12M
10-K · filed 2018-02-27
2015-09-30$92.92K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04
$92.92K
derived: sum of 2 quarters · filed 2016-11-04
$92.92K
10-Q · filed 2016-11-04
$92.92K
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10
$0.00
10-Q · filed 2016-08-10
$0.00
derived: sum of 3 quarters · filed 2017-02-28
2015-03-31$0.00
10-Q · filed 2016-05-06
$0.00
derived: sum of 2 quarters · filed 2017-02-28
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$0.00
10-K · filed 2017-02-28
2014-09-30$0.00
10-Q · filed 2015-11-06
2013-12-31$0.00
10-K · filed 2016-03-14